Find Ivermectin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

USP

0

JP

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Ivermectin, Dihydroavermectin b1a, 70288-86-7, 22,23-dihydroavermectin b1a, 70161-11-4, Ivermectin component b1a
Molecular Formula
C48H74O14
Molecular Weight
875.1  g/mol
InChI Key
AZSNMRSAGSSBNP-XPNPUAGNSA-N
FDA UNII
91Y2202OUW

Ivermectin
A mixture of mostly avermectin H2B1a (RN 71827-03-7) with some avermectin H2B1b (RN 70209-81-3), which are macrolides from STREPTOMYCES avermitilis. It binds glutamate-gated chloride channel to cause increased permeability and hyperpolarization of nerve and muscle cells. It also interacts with other CHLORIDE CHANNELS. It is a broad spectrum antiparasitic that is active against microfilariae of ONCHOCERCA VOLVULUS but not the adult form.
1 2D Structure

Ivermectin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2S)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one
2.1.2 InChI
InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1
2.1.3 InChI Key
AZSNMRSAGSSBNP-XPNPUAGNSA-N
2.1.4 Canonical SMILES
CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C
2.1.5 Isomeric SMILES
CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C
2.2 Other Identifiers
2.2.1 UNII
91Y2202OUW
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Eqvalan

2. Ivermectin

3. Ivomec

4. Mectizan

5. Mk 933

6. Mk-933

7. Mk933

8. Stromectol

2.3.2 Depositor-Supplied Synonyms

1. Ivermectin

2. Dihydroavermectin B1a

3. 70288-86-7

4. 22,23-dihydroavermectin B1a

5. 70161-11-4

6. Ivermectin Component B1a

7. 71827-03-7

8. Avermectin H2b1a

9. 5-o-demethyl-22,23-dihydroavermectin A1a

10. Chebi:63941

11. 91y2202ouw

12. (2ae,4e,5's,6s,6'r,7s,8e,11r,13r,15s,17ar,20r,20ar,20bs)-6'-[(2s)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19-tetramethyl-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2h,7h-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-o-(2,6-dideoxy-3-o-methyl-alpha-l-arabino-hexopyranosyl)-3-o-methyl-alpha-l-arabino-hexopyranoside

13. Mk-933

14. (1r,4s,5's,6r,6'r,8r,10e,12s,13s,14e,16e,20r,21r,24s)-6'-[(2s)-butan-2-yl]-21,24-dihydroxy-12-[(2r,4s,5s,6s)-5-[(2s,4s,5s,6s)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one

15. Ivermectin B1a-d2

16. C48h74o14

17. Unii-91y2202ouw

18. 22,23-dihydroavermectin B(1)a

19. Ncgc00163233-01

20. Ivermectin (ivm)

21. Ivm

22. Einecs 276-046-2

23. Dihydro Avermectin Bla

24. Brn 4643153

25. 22,23-dihydro-5-o-demethylavermectin A1a

26. H2b1a

27. Prestwick3_000156

28. Dsstox_cid_3181

29. Ivermectin (mk-0933)

30. Dsstox_rid_76909

31. Dsstox_gsid_23181

32. Bspbio_000292

33. Schembl312795

34. Bpbio1_000322

35. Chembl263291

36. Dtxsid8023181

37. Chebi:94551

38. Hms2089m09

39. Hms2095o14

40. Hms3712o14

41. Wca82703

42. Tox21_112034

43. Bdbm50409816

44. Mfcd30496678

45. S1351

46. Akos027470116

47. Ivermectin Component B1a [mi]

48. Zinc238808778

49. Zinc252286706

50. Ac-6014

51. Ccg-220156

52. Ncgc00186639-01

53. Ncgc00186639-03

54. As-14167

55. Bi166167

56. Cas-71827-03-7

57. Hy-126937

58. Ab00513813

59. Cs-0108408

60. 22,23-dihydroavermectin B1a; Ivermectin

61. Ab00513813-02

62. Ab00513813-03

63. Ab00513813_04

64. Avermectin A1a, 22,23-dihydro-5-o-demethyl-

65. 288i867

66. Ivermectin, Antibiotic For Culture Media Use Only

67. Q-201262

68. Brd-k24652731-001-02-7

69. Brd-k85554912-001-08-9

70. Q27132923

71. Ivermectin, British Pharmacopoeia (bp) Reference Standard

72. Ivermectin, European Pharmacopoeia (ep) Reference Standard

73. Ivermectin, United States Pharmacopeia (usp) Reference Standard

74. Ivermectin, Pharmaceutical Secondary Standard; Certified Reference Material

75. (2ae,4e,5's,6s,6'r,7s,8e,11r,13r,15s,17ar,20r,20ar,20bs)-6'-[(2s)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19-tetramethyl-17

76. Clooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-o-(2,6-dideoxy-3-o-methyl-alpha-l-arabino-hexopyranosyl)-3-o-methyl-alpha-l-arabino-hexopyranoside

2.4 Create Date
2005-11-20
3 Chemical and Physical Properties
Molecular Weight 875.1 g/mol
Molecular Formula C48H74O14
XLogP34.1
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count14
Rotatable Bond Count8
Exact Mass874.50785703 g/mol
Monoisotopic Mass874.50785703 g/mol
Topological Polar Surface Area170 Ų
Heavy Atom Count62
Formal Charge0
Complexity1680
Isotope Atom Count0
Defined Atom Stereocenter Count20
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count3
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Treatment of rosacea


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Antiparasitic Agents

Drugs used to treat or prevent parasitic infections. (See all compounds classified as Antiparasitic Agents.)


Insecticides

Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Pediculicide [EPC]; Antiparasitic [EPC]
5.3 ATC Code

D - Dermatologicals

D11 - Other dermatological preparations

D11A - Other dermatological preparations

D11AX - Other dermatologicals

D11AX22 - Ivermectin


P - Antiparasitic products, insecticides and repellents

P02 - Anthelmintics

P02C - Antinematodal agents

P02CF - Avermectines

P02CF01 - Ivermectin


USDMF

read-more
read-moreread-more

01

Delta Tech Ltd

Taiwan

USDMF

arrow
AMWC Asia-TDAC
Not Confirmed

01

AMWC Asia-TDAC
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 17673

Submission : 2004-07-18

Status : Inactive

Type : II

blank

02

Hovione Pharmascience Ltd

Portugal

USDMF

arrow
AMWC Asia-TDAC
Not Confirmed

02

AMWC Asia-TDAC
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2013-01-09

Pay. Date : 2012-12-14

DMF Number : 21395

Submission : 2008-03-05

Status : Active

Type : II

blank

03

AMWC Asia-TDAC
Not Confirmed

03

AMWC Asia-TDAC
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2022-04-06

Pay. Date : 2022-01-13

DMF Number : 36494

Submission : 2021-11-15

Status : Active

Type : II

blank

04

AMWC Asia-TDAC
Not Confirmed

04

AMWC Asia-TDAC
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2014-02-08

Pay. Date : 2012-12-18

DMF Number : 21624

Submission : 2008-05-08

Status : Active

Type : II

blank

05

Haimen Pharmaceutical Factory

Country

USDMF

arrow
AMWC Asia-TDAC
Not Confirmed

05

Haimen Pharmaceutical Factory

Country
arrow
AMWC Asia-TDAC
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 12755

Submission : 1997-11-21

Status : Inactive

Type : II

blank

06

Hebei Meihe Pharmaceutical Co Ltd

Country

USDMF

arrow
AMWC Asia-TDAC
Not Confirmed

06

Hebei Meihe Pharmaceutical Co Ltd

Country
arrow
AMWC Asia-TDAC
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 38553

Submission : 2023-06-27

Status : Active

Type : II

blank

07

Shanghai Tongren Pharmaceutical Co L...

Country

USDMF

arrow
AMWC Asia-TDAC
Not Confirmed

07

Shanghai Tongren Pharmaceutical Co L...

Country
arrow
AMWC Asia-TDAC
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 13037

Submission : 1998-06-15

Status : Inactive

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

LGM Pharma

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content

Ivermectin

About the Company : LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product ...

LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product CDMO, offering formulation, analytical method development and testing, regulatory support, and commercial manufacturing. Supported by a network of over 220 accredited cGMP manufacturing partners and more than 100,000 sq. ft. of FDA-inspected cGMP manufacturing and warehouse space, LGM delivers secure, end-to-end solutions across multiple dosage forms. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
LGM Pharma CB

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

Flag India
Digital Content Digital Content

Ivermectin

About the Company : Jai Radhe Sales, founded in 1999, is a global distributor specializing in high-quality pharmaceutical ingredients from India. It offers complete sourcing solutions, technical and r...

Jai Radhe Sales, founded in 1999, is a global distributor specializing in high-quality pharmaceutical ingredients from India. It offers complete sourcing solutions, technical and regulatory support, and strives for global standards. Known for quality and affordability, it has established a niche through innovative methods and exports to nearly every continent. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Jai Radhe Sales

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWillow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

Flag U.S.A
Digital Content Digital Content

Ivermectin

About the Company : Willow Birch Pharma, Inc. is a premier supplier of bulk APIs to North American Compounding Pharmacies, sourcing from FDA registered and GMP manufacturers. With licenses in all 50 s...

Willow Birch Pharma, Inc. is a premier supplier of bulk APIs to North American Compounding Pharmacies, sourcing from FDA registered and GMP manufacturers. With licenses in all 50 states as a drug wholesaler and NABP accreditation since 2007, Willow Birch Pharma delivers top-quality products at competitive prices with unparalleled service and regulatory support nationwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

04

CHEMO

Spain
AMWC Asia-TDAC
Not Confirmed
arrow

CHEMO

Spain
arrow
AMWC Asia-TDAC
Not Confirmed

Ivermectin

About the Company : More than 35 years of dedication to quality, service and pursuit of excellence, CHEMO was founded by Hugo Sigman, M.D., and Silvia Gold, Biochemist, in Spain (Barcelona), in 1977, ...

More than 35 years of dedication to quality, service and pursuit of excellence, CHEMO was founded by Hugo Sigman, M.D., and Silvia Gold, Biochemist, in Spain (Barcelona), in 1977, and starts business activities trading with pharmaceutical raw materials. In the 80's, the company expanded its operations into the Industrial Business, developing and manufacturing active pharmaceutical ingredients (APIs) in Italy (Industriale Chimica) and in Spain (Quimica Sintetica). In the 90's, CHEMO starts developing and manufacturing high quality and technology finished dosage forms (FDFs).
blank

05

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Ivermectin

About the Company : Hebei Veyong Pharmaceutical Co., Ltd, was established in 2002 and located in Economic and Technological Development Zone in Shijiazhuang. It is a large veterinary enterprise with G...

Hebei Veyong Pharmaceutical Co., Ltd, was established in 2002 and located in Economic and Technological Development Zone in Shijiazhuang. It is a large veterinary enterprise with GMP certificate in China with research and development, production and sales of veterinary API and preparations. It is national high-tech enterprise, Hebei famous trademark enterprise, the vice-chairman company of Hebei Association of Animal Science and Veterinary Medicine, the vice-chairman company of Hebei Animal Health Products Association.
blank

06

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Ivermectin

About the Company : HENGDIAN GROUP was established in 1975, till now it has become a transnational,conglomerate group and been one of the largest private-owned enterprises in China. The Pharmaceutical...

HENGDIAN GROUP was established in 1975, till now it has become a transnational,conglomerate group and been one of the largest private-owned enterprises in China. The Pharmaceutical & Chemical division has 3 sub-companies with over 3,000 employees of which over 30% are technicians; This division is mainly producing APIs, Agrochemical and Dyestuffs with related intermediates as well as other special chemicals. The group also focuses on CONTRACT MANUFACTURE service under GMP and confidential agreement with our clients.
blank

07

Hovione

Portugal
AMWC Asia-TDAC
Not Confirmed
arrow

Hovione

Portugal
arrow
AMWC Asia-TDAC
Not Confirmed

Ivermectin

About the Company : Hovione is an international company with over 60 years of experience as a Contract Development and Manufacturing Organization (CDMO) with a fully integrated offering of services fo...

Hovione is an international company with over 60 years of experience as a Contract Development and Manufacturing Organization (CDMO) with a fully integrated offering of services for drug substance, drug product intermediate and drug product. The company has four FDA inspected sites. Hovione provides pharmaceutical customers services for the development and compliant manufacture of innovative drugs, including highly potent compounds, and customized product solution across the entire drug life cycle. In the inhalation area, Hovione offers a complete range of services, from API, formulation development and devices.
blank

08

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Ivermectin

About the Company : Consistent growth and sustainability is a multidimensional aspiration for all at Macleods, we remained focused on providing quality and affordable medicines to billions of ailing p...

Consistent growth and sustainability is a multidimensional aspiration for all at Macleods, we remained focused on providing quality and affordable medicines to billions of ailing patients across geographies and bridging the gap of unmet needs of medical fraternity through continuous innovation. Our basic business philosophy, by its very nature, serves a social responsibility hence we have a far better reason than profits alone to drive our performance. Sustainability, is not a trend we blindly follow, it is intrinsic to how we have operated since the genesis of the organization in the year 1986.
blank

09

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Ivermectin

About the Company : Established in the year 2002, we are known to be a well established Exporter, Manufacturer and Supplier in India. Being a quality centric firm, we are committed to offer a range Ac...

Established in the year 2002, we are known to be a well established Exporter, Manufacturer and Supplier in India. Being a quality centric firm, we are committed to offer a range Active Pharmaceutical Ingredients (API), Bulk Drug Intermediates, and Veterinary Medicines including IVERMECTIN EP, etc. All the products are processed by a team of highly experienced professionals, under expert guidance. Furthermore, our quality analysts check the processed range on the basis of varied parameters such as composition, pH value, viscosity, packaging, etc. We pack our products using best of materials.
blank

10

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Ivermectin

About the Company : Sinobright Pharmaceutical Co., Ltd. Founded in 2003, with ISO & GSP(Good Supply Practice) Certificate, which is specialized in sourcing for APIs,Intermediates,Chemicals and other r...

Sinobright Pharmaceutical Co., Ltd. Founded in 2003, with ISO & GSP(Good Supply Practice) Certificate, which is specialized in sourcing for APIs,Intermediates,Chemicals and other related products.Sinobright has accumulated large wide domestic partnership network to provide overseas customers with diverse of value-added services,including the plant auditing for the requirements of EDQM and FDA,introduce or recommend new APIs to regulated markets,custom synthesis service for lab scare to plant scare, regulatory affairs and consulting services.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - LOTION;TOPICAL - 0.5%

USFDA APPLICATION NUMBER - 202736

read-more

DOSAGE - CREAM;TOPICAL - 1%

USFDA APPLICATION NUMBER - 206255

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Topical

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Solubilizers

read-more
read-more

Direct Compression

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Parenteral

read-more
read-more

Co-Processed Excipients

read-more
read-more

Emulsifying Agents

read-more
read-more

Lubricants & Glidants

read-more
read-more

Granulation

read-more
read-more

Taste Masking

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

API Stability Enhancers

read-more
read-more

Rheology Modifiers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Coating Systems & Additives

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ANALYTICAL

Upload your methods for free, ask us

ABOUT THIS PAGE

Looking for 71827-03-7 / Ivermectin API manufacturers, exporters & distributors?

Ivermectin manufacturers, exporters & distributors 1

47

PharmaCompass offers a list of Ivermectin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ivermectin manufacturer or Ivermectin supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ivermectin manufacturer or Ivermectin supplier.

API | Excipient name

Ivermectin

Synonyms

Dihydroavermectin b1a, 70288-86-7, 22,23-dihydroavermectin b1a, 70161-11-4, Ivermectin component b1a, 71827-03-7

Cas Number

71827-03-7

Unique Ingredient Identifier (UNII)

91Y2202OUW

About Ivermectin

A mixture of mostly avermectin H2B1a (RN 71827-03-7) with some avermectin H2B1b (RN 70209-81-3), which are macrolides from STREPTOMYCES avermitilis. It binds glutamate-gated chloride channel to cause increased permeability and hyperpolarization of nerve and muscle cells. It also interacts with other CHLORIDE CHANNELS. It is a broad spectrum antiparasitic that is active against microfilariae of ONCHOCERCA VOLVULUS but not the adult form.

Stromectol Manufacturers

A Stromectol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Stromectol, including repackagers and relabelers. The FDA regulates Stromectol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Stromectol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Stromectol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Stromectol Suppliers

A Stromectol supplier is an individual or a company that provides Stromectol active pharmaceutical ingredient (API) or Stromectol finished formulations upon request. The Stromectol suppliers may include Stromectol API manufacturers, exporters, distributors and traders.

click here to find a list of Stromectol suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Stromectol USDMF

A Stromectol DMF (Drug Master File) is a document detailing the whole manufacturing process of Stromectol active pharmaceutical ingredient (API) in detail. Different forms of Stromectol DMFs exist exist since differing nations have different regulations, such as Stromectol USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Stromectol DMF submitted to regulatory agencies in the US is known as a USDMF. Stromectol USDMF includes data on Stromectol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Stromectol USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Stromectol suppliers with USDMF on PharmaCompass.

Stromectol JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Stromectol Drug Master File in Japan (Stromectol JDMF) empowers Stromectol API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Stromectol JDMF during the approval evaluation for pharmaceutical products. At the time of Stromectol JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Stromectol suppliers with JDMF on PharmaCompass.

Stromectol KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Stromectol Drug Master File in Korea (Stromectol KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Stromectol. The MFDS reviews the Stromectol KDMF as part of the drug registration process and uses the information provided in the Stromectol KDMF to evaluate the safety and efficacy of the drug.

After submitting a Stromectol KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Stromectol API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Stromectol suppliers with KDMF on PharmaCompass.

Stromectol CEP

A Stromectol CEP of the European Pharmacopoeia monograph is often referred to as a Stromectol Certificate of Suitability (COS). The purpose of a Stromectol CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Stromectol EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Stromectol to their clients by showing that a Stromectol CEP has been issued for it. The manufacturer submits a Stromectol CEP (COS) as part of the market authorization procedure, and it takes on the role of a Stromectol CEP holder for the record. Additionally, the data presented in the Stromectol CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Stromectol DMF.

A Stromectol CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Stromectol CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Stromectol suppliers with CEP (COS) on PharmaCompass.

Stromectol NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Stromectol as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Stromectol API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Stromectol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Stromectol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Stromectol NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Stromectol suppliers with NDC on PharmaCompass.

Stromectol GMP

Stromectol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Stromectol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Stromectol GMP manufacturer or Stromectol GMP API supplier for your needs.

Stromectol CoA

A Stromectol CoA (Certificate of Analysis) is a formal document that attests to Stromectol's compliance with Stromectol specifications and serves as a tool for batch-level quality control.

Stromectol CoA mostly includes findings from lab analyses of a specific batch. For each Stromectol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Stromectol may be tested according to a variety of international standards, such as European Pharmacopoeia (Stromectol EP), Stromectol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Stromectol USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty